integrating her2-targeted strategies into the management of gastrointestinal cancers
Published 1 month ago • 146 plays • Length 1:00:59Download video MP4
Download video MP3
Similar videos
-
1:00:59
inside the issue: integrating her2-targeted strategies into the management of gastrointestinal ca...
-
37:10
role of her2-directed therapy in the treatment of her2-expressing gastro cancers
-
56:47
her2-targeted strategies for her2-positive gastro and colorectal cancers — john strickler, md
-
37:25
role of her2-directed therapy in the treatment of her2-expressing gastrointestinal cancers
-
5:45
her2-positive breast cancer: a paradigm shift in diagnosis and therapy
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
32:57
role of her2-directed therapy in the treatment of her2-expressing gyn cancers (companion lecture)
-
8:04
management of her2 cancers - integrating new data into clinical practice
-
1:18:52
her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents
-
32:21
emerging role of her2-targeted therapy in btcs — tanios bekaii-saab, md
-
59:18
optimizing novel her2-targeted therapies and other agents in gastric cancer care
-
0:34
her2-targeted therapies
-
1:07:30
oncology today with dr neil love: role of her2-directed therapy in the treatment of her2-expressing
-
21:57
therapeutic management of biliary cancers: integrating precision medicine with targeted strategies
-
48:00
enhancing treatment strategies with molecular approaches in her2 gastrointestinal cancers
-
3:50
her2 positive breast and stomach cancer treatment herceptin (trastuzumab)
-
31:17
molecular testing and the role of her2 in managing advanced colorectal cancer
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
1:24
treatment de-escalation and escalation strategies in her2-positive breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer